This prestigious recognition highlights OASYS NOW’s commitment to revolutionizing healthcare through innovative and secure AI solutions.
The ELSA initiative, aimed at fostering collaboration between startups and leading AI researchers, selected OASYS NOW from over 200 applicants. The company’s groundbreaking work focuses on enabling personalized healthcare for all while upholding the highest standards of data privacy and security.
Key Partnerships Fueling Innovation
OASYS NOW’s success is further bolstered by strategic partnerships with industry leaders:
NVIDIA: Providing early access to specialized GPUs and technical support through their Inception Program.
Erasmus MC: Professor Gennady Roshchupkin and his team are overseeing a critical use case for biomarker discovery, leveraging deep-learning genetic research tools.
CISPA Helmholtz Center for Information Security: Overseeing the project and providing expertise on security, privacy, and cryptography technologies.
A Vision for Secure and Collaborative Healthcare
We believe that Privacy Enhancing Technologies and federated approaches are essential for conducting cross-border clinical research.Collaborating with ELSA and esteemed partners like NVIDIA and Erasmus MC allows us to accelerate our efforts towards a future where personalized healthcare is a reality for everyone.
Professor Mario Fritz, ELSA Coordinator, emphasized the value of this collaboration:
The exchange with young entrepreneurs working on innovative AI applications is of great value to ELSA. It enables the top researchers in the ELSA network to contribute their expertise to the development of applications and thus to advance the projects significantly.
About OASYS NOW
OASYS NOW is a Dutch company dedicated to developing privacy-by-design and patient-first technologies that transform the use of health data in clinical research and healthcare. Their solutions empower researchers and healthcare providers while ensuring the utmost protection of patient privacy.
Follow OASYS NOW on LinkedIn for updates on their exciting innovations in the Healthcare and Life Science industry.